Universidade Do Porto
Clinical trials sponsored by Universidade Do Porto, explained in plain language.
-
Heart failure drug combo: is starting both at once safe?
Disease control CompletedThis study looked at 62 adults with heart failure and reduced pumping ability. Researchers compared starting two medications (sacubitril/valsartan and an SGLT2 inhibitor) at the same time versus starting one drug first and adding the other later. The goal was to see which approac…
Phase: PHASE4 • Sponsor: Universidade do Porto • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Overnight leg lift device shows promise for vein sufferers
Symptom relief CompletedThis study tested whether sleeping with the UZit® device, which elevates the legs overnight, can ease symptoms of chronic venous disease. Seventeen adults used the device every night for one week while continuing their usual care. Researchers measured changes in quality of life, …
Phase: NA • Sponsor: Universidade do Porto • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC
-
Hidden heart risk: fabry disease found in unexplained cardiomyopathy patients
Knowledge-focused CompletedThis study looked at 409 Portuguese adults with unexplained heart muscle disease (cardiomyopathy) to see how many had Fabry disease, a rare genetic condition. Researchers tested patients with different types of heart problems, such as thickened or weakened heart muscle. The goal …
Sponsor: Universidade do Porto • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:03 UTC